Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates

Triple negative breast cancer (TNBC) accounts for about a fifth of all breast cancers and includes a diverse group of cancers. The heterogeneity of TNBC and the lack of target receptors on the cell surface make it difficult to develop specific therapeutic treatments. These aspects cause the high neg...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertoli, Gloria, Cava, Claudia, Corsi, Fabio, Piccotti, Francesca, Martelli, Cristina, Ottobrini, Luisa, Vaira, Valentina, Castiglioni, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985188/
https://www.ncbi.nlm.nih.gov/pubmed/33753785
http://dx.doi.org/10.1038/s41598-021-85746-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985188/
https://www.ncbi.nlm.nih.gov/pubmed/33753785
http://dx.doi.org/10.1038/s41598-021-85746-w

Ejemplares similares